RSCM
MIRM icon

Rock Springs Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$41.6M Sell
818,206
-133,559
-14% -$6.8M 2.59% 10
2025
Q1
$42.9M Sell
951,765
-519,799
-35% -$23.4M 2.45% 12
2024
Q4
$60.8M Sell
1,471,564
-108,924
-7% -$4.5M 2.32% 11
2024
Q3
$61.6M Sell
1,580,488
-191,550
-11% -$7.47M 2.01% 12
2024
Q2
$60.6M Sell
1,772,038
-84,526
-5% -$2.89M 1.82% 14
2024
Q1
$46.6M Buy
1,856,564
+5,100
+0.3% +$128K 1.18% 31
2023
Q4
$54.7M Buy
1,851,464
+30,731
+2% +$907K 1.35% 24
2023
Q3
$57.5M Hold
1,820,733
1.54% 22
2023
Q2
$47.1M Buy
1,820,733
+25,000
+1% +$647K 1.12% 30
2023
Q1
$43.1M Hold
1,795,733
1.03% 32
2022
Q4
$35M Hold
1,795,733
0.84% 42
2022
Q3
$37.7M Buy
1,795,733
+78,000
+5% +$1.64M 0.97% 38
2022
Q2
$33.4M Buy
1,717,733
+51,525
+3% +$1M 0.97% 36
2022
Q1
$36.7M Buy
1,666,208
+127,394
+8% +$2.81M 0.92% 37
2021
Q4
$24.5M Buy
1,538,814
+13,191
+0.9% +$210K 0.57% 56
2021
Q3
$30.4M Buy
1,525,623
+1,900
+0.1% +$37.8K 0.64% 51
2021
Q2
$26.3M Buy
1,523,723
+20,923
+1% +$362K 0.52% 58
2021
Q1
$29.8M Buy
1,502,800
+6,275
+0.4% +$124K 0.65% 53
2020
Q4
$26.1M Buy
1,496,525
+168,911
+13% +$2.95M 0.55% 59
2020
Q3
$25.6M Buy
1,327,614
+7,704
+0.6% +$148K 0.65% 52
2020
Q2
$25.7M Buy
1,319,910
+76,910
+6% +$1.5M 0.7% 53
2020
Q1
$17.4M Sell
1,243,000
-2,000
-0.2% -$28K 0.72% 49
2019
Q4
$30.5M Buy
1,245,000
+454,952
+58% +$11.2M 0.96% 39
2019
Q3
$7.95M Buy
+790,048
New +$7.95M 0.32% 84